Generics Producers in Asia: Where Are the Big Opportunities

Generics Producers in Asia: Where Are the Big Opportunities provides newly researched company profiles and competitive intelligence on 50 leading generics producers (see full list below) operating in 14 key markets: Australia, China, Hong Kong, India, Indonesia, Japan, Malaysia, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.

Generics Producers in Asia: Where Are the Big Opportunities also evaluates key industry trends and growth dynamics, and features BMI' s independent 5-year industry forecasts for each market to end-2012. Each of the 14 generics markets is also ranked according to the competitiveness of the regulatory and business operating environment, and growth potential of the generics segment over the 5-year forecast horizon.

BMI Asia Generics View

BMI values the Asian generic drug sector at US$41.8bn, and we forecast 12.7% year-on-year growth through 2012. Generics Producers in Asia: Where Are the Big Opportunities examines the key drivers of this rapid growth (growing economies, cost-containment policies, ageing populations and the emergence of chronic diseases), and the opportunities arising for multinational and local generics producers alike.